Arena Pharmaceuticals (ARNA) stock forecast for 2022 – 2027

Are you interested in Arena Pharmaceuticals, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ARNA stock price in 2022-2027. Is ARNA a good long term stock? When should I take profit in Arena Pharmaceuticals stock? Buy or sell stock? Will ARNA stock price go up? What are analysts’ forecasts for ARNA stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. ARNA stock returns are also predicted based on historical data.

According to our research, ARNA stock is a good long-term investment. ARNA share price has been in a positive cycle for the past year. Arena Pharmaceuticals, Inc. stock trend is positive.

Arena Pharmaceuticals company info

Industry Biotechnology
Address 136 Heber Avenue, Park City, UT, 84060, United States
Website https://www.arenapharm.com

Forecasting

52 Week High: 105.88 USD
52 Week Low: 91.5817 USD
1 Year Forecast: 103.418 USD
5 Year Forecast: 144.198 USD

Agilent Technologies info

Market Cap: 5.66B
52 Week Change: 12.598%
52 Week High: 94.23 USD
52 Week Low: 45.5 USD
Beta: 0.51291
50 Day Moving Average: 91.9
90 Day Moving Average: 76.612
200 Day Moving Average: 66.14
Resistance Level: 94.6138
Pivot Point: 90.8751
Support Level: 90.107
Enterprise Value: 4,951,198,208
Forward P/E: -10.81
Forward EPS: -8.44
Profit Margin: 0.00%
Shares Outstanding: 61,564,100
EBITDA: -9.30
Held Percent Institutions: 93.33%
PEG Ratio (5Y): 0.46
Trailing EPS: -9.72

Arena Pharmaceuticals stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Arena Pharmaceuticals Stock Forecast for 2022

March 2022 90.09 88.2 -2.1%
April 2022 89.1 89.18 0.09%
May 2022 92.82 97.92 5.49%
June 2022 94.08 103.02 9.5%
July 2022 103.02 100.94 -2.02%
August 2022 100.98 98 -2.95%
September 2022 103.02 97.92 -4.95%
October 2022 96.96 95.95 -1.04%
November 2022 92.12 96 4.21%
December 2022 96 98.98 3.1%

Arena Pharmaceuticals Stock Forecast for 2023

January 2023 100.98 100.98 0%
February 2023 103.02 101.97 -1.02%
March 2023 100.94 98.98 -1.94%
April 2023 102.01 102.01 0%
May 2023 99.96 104.86 4.9%
June 2023 108 112 3.7%
July 2023 110.88 116.28 4.87%
August 2023 114.13 109.76 -3.83%
September 2023 109.76 107 -2.51%
October 2023 107 107.06 0.06%
November 2023 107.1 108.07 0.91%
December 2023 105.93 114.24 7.84%

Arena Pharmaceuticals Stock Forecast for 2024

January 2024 110.74 114.13 3.06%
February 2024 111.87 111.72 -0.13%
March 2024 114 113.12 -0.77%
April 2024 114.13 113 -0.99%
May 2024 111.87 117.81 5.31%
June 2024 121.38 125.46 3.36%
July 2024 124 127.5 2.82%
August 2024 122.76 121.77 -0.81%
September 2024 124.23 115.64 -6.91%
October 2024 118 115.83 -1.84%
November 2024 119.34 120.36 0.85%
December 2024 121.38 121.52 0.12%

Arena Pharmaceuticals Stock Forecast for 2025

January 2025 125.24 122.76 -1.98%
February 2025 126.25 123.75 -1.98%
March 2025 127.5 122.76 -3.72%
April 2025 124 121.52 -2%
May 2025 126.25 126.42 0.13%
June 2025 131.3 135 2.82%
July 2025 135 136 0.74%
August 2025 133.28 135.34 1.55%
September 2025 132.66 126.42 -4.7%
October 2025 131.58 129.28 -1.75%
November 2025 129.28 126.42 -2.21%
December 2025 131.3 136.35 3.85%

Arena Pharmaceuticals Stock Forecast for 2026

January 2026 132.3 137.7 4.08%
February 2026 136 138.37 1.74%
March 2026 134.64 136.35 1.27%
April 2026 136.35 132.3 -2.97%
May 2026 134.64 137.2 1.9%
June 2026 143.82 146 1.52%
July 2026 147.46 147 -0.31%
August 2026 145.53 143.55 -1.36%
September 2026 143.55 139.59 -2.76%
October 2026 139.59 137.61 -1.42%
November 2026 139 143.82 3.47%
December 2026 143.82 147.46 2.53%

Arena Pharmaceuticals Stock Forecast for 2027

January 2027 143.08 147 2.74%